PAFAH (PLA2G7) (NM_001168357) Human Recombinant Protein
CAT#: TP720487M
Recombinant protein of human phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (PLA2G7), transcript variant 2.
Need it in bulk or customized? Get a free quote |
CNY 7,220.00
货期*
2周
规格
经常一起买 (1)
Specifications
Product Data | |
Species | Human |
Expression Host | HEK293 |
Expression cDNA Clone or AA Sequence |
Phe22-Asn441
|
Tag | C-His |
Predicted MW | 48.8 kDa |
Concentration | lot specific |
Purity | >95% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | Supplied as a 0.2 um filtered solution of 50mM NaAc, 150mM NaCl, 10% Glycerol, pH 5.0. |
Storage | Store at < -20°C, stable for 6 months after receipt. Please minimize freeze-thaw cycles. |
Stability | Stable for at least 3 months from date of receipt under proper storage and handling conditions. |
Endotoxin | < 0.1 EU per µg protein as determined by LAL test |
Reference Data | |
RefSeq | NP_001161829 |
Locus ID | 7941 |
UniProt ID | Q13093 |
Cytogenetics | 6p12.3 |
Synonyms | LDL-PLA2; LP-PLA2; PAFAD; PAFAH |
Summary | The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2009] |
Protein Families | Druggable Genome, Secreted Protein |
Protein Pathways | Ether lipid metabolism, Metabolic pathways |
Documents
FAQs |
SDS |
Customer
Reviews
Loading...